2015 Taubman Prize
For Excellence in Translational Medical Science
This award is presented annually by the A. Alfred Taubman Medical Research Institute at the University of Michigan. It is meant to recognize work in the crucial field of translational research being conducted by the clinician-scientist who has done the most to transform laboratory discoveries into clinical applications for patients suffering from disease.
- International scientists are eligible.
- U-M scientists are excluded.
- Self-nomination is permitted.
- The recipient must be available to deliver the keynote speech at the Taubman Institute annual symposium Oct. 16, 2015 in Ann Arbor, Mich.
- Significant contribution to translating basic research findings into medical practice
- The manner in which nominee’s clinical activities connects to his or her laboratory research
Deadline: February 1, 2015
For a nomination to be considered by the selection committee, the following items must be submitted with the completed nomination form:
- A one-page letter of nomination detailing the individual’s extraordinary or sustained contribution to the field of translational research
- The curriculum vitae of the nominee
- A bibliography of 5 most significant publications
- Two additional letters of support
Electronic submissions are encouraged. Incomplete nominations will not be presented to the nomination committee.
Taubman-sponsored research offers breast tumor insights
Taubman Emerging Scholar Dr. Scott Tomlins has authored a new study about phyllodes tumors.
New U-M President visits Taubman Institute
The Institute hosted a fellow clinician-scientist when the University of Michigan’s new president paid a visit to the A. Alfred Taubman Biomedical Science Research Building.
Familial ALS affects generations
Detroit News column featuring Dr. Eva Feldman depicts the toll of the disease on one Metro Detroit family
news & events
In the News
Taubman Emerging Scholar makes strides against cancer
Erika Newman, M.D., has identified a characteristic of deadly childhood neuroblastoma that may pave the way for more effective treatments.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.